IPG
49
10
AMAT
36
5
PVH
52
-3
ZTS
47
2
AMP
69
-3
DD
56
3
NTAP
64
2
EXPE
88
2
TXT
48
2
T
50
3
LH
42
2
ED
48
3
ICE
59
-3
HRB
51
2
KR
34
-3
PNW
66
3
ADP
64
2
IBM
54
4
ORLY
53
-3
BA
52
2
IPG
49
10
AMAT
36
5
PVH
52
-3
ZTS
47
2
AMP
69
-3
DD
56
3
NTAP
64
2
EXPE
88
2
TXT
48
2
T
50
3
LH
42
2
ED
48
3
ICE
59
-3
HRB
51
2
KR
34
-3
PNW
66
3
ADP
64
2
IBM
54
4
ORLY
53
-3
BA
52
2
Financhill
Back

NovaBay Pharmaceuticals Vs. iBio Industry Stock Comparison

Sell
30

NBY
NovaBay Pharmaceuticals

Last Price:
0.72
Seasonality Move:
-0.57%
Sell
22

IBIO
iBio

Last Price:
2.45
Seasonality Move:
-11.6%
Sell
30
NovaBay Pharmaceuticals (NBY) is a Sell

Is NovaBay Pharmaceuticals a Buy, Sell or Hold?

  • The current NovaBay Pharmaceuticals [NBY] share price is $0.71. The Score for NBY is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
  • NBY is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
22
iBio (IBIO) is a Sell

Is iBio a Buy, Sell or Hold?

  • The current iBio [IBIO] share price is $2.19. The Score for IBIO is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.
  • IBIO is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

NBY Stock Price Chart

What is NovaBay Pharmaceuticals's stock price today?

  • The NovaBay Pharmaceuticals share price today is $0.71
    The current trend is relatively stagnant and NBY is experiencing slight buying pressure.

IBIO Stock Price Chart

What is iBio's stock price today?

  • The iBio share price today is $2.19
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and IBIO is experiencing selling pressure, which indicates risk of future bearish movement.

NBY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.02 Buy
Relative Strength Index (14 RSI): 53 Buy
Chaikin Money Flow: 9133 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.61 - 0.75) Buy
Bollinger Bands (100): (0.28 - 1.48) Sell

IBIO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.09 Sell
Relative Strength Index (14 RSI): 37.39 Sell
Chaikin Money Flow: -44380 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (2.36 - 2.86) Sell
Bollinger Bands (100): (1.84 - 2.54) Sell

NBY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.72 Sell
20-day SMA: 0.7 Buy
50-day SMA: 0.65 Buy
200-day SMA: 2.37 Sell
8-day EMA: 0.71 Sell
20-day EMA: 0.7 Buy
50-day EMA: 0.73 Sell
200-day EMA: 5.67 Sell

IBIO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 2.31 Sell
20-day SMA: 2.54 Sell
50-day SMA: 2.4 Sell
200-day SMA: 2.02 Buy
8-day EMA: 2.3 Sell
20-day EMA: 2.44 Sell
50-day EMA: 2.4 Sell
200-day EMA: 3.91 Sell

NovaBay Pharmaceuticals Earnings Growth & NBY Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $77.59 per share, and an increase next year of $2.44 per share.

iBio Earnings Growth & IBIO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $103.99 per share, and an increase next year of $5.67 per share.

NovaBay Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

iBio Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):